Eph receptor tyrosine kinases (RTK) and their ephrin ligands are involved in the transmission of signals which regulate cytoskeletal organisation and cell migration, and are expressed in spatially restricted patterns at discrete phases during embryogenesis. Loss of function mutants of Eph RTK or ephrin genes result in defects in neuronal path®nding or cell migration. In this report we show that soluble forms of human EphA3 and ephrin-A5, acting as dominant negative inhibitors, interfere with early events in zebra®sh embryogenesis. Exogenous expression of both proteins results in dose-dependent defects in somite development and organisation of the midbrain-hindbrain boundary and hindbrain. The nature of the defects as well as the distribution and timing of expression of endogenous ligands/receptors for both proteins suggest that Eph-ephrin interaction is required for the organisation of embryonic structures by coordinating the cellular movements of convergence during gastrulation. q
Introduction
Complex and cellular movements form the three primary germ layers lay out the architecture of the vertebrate body during gastrulation (reviewed in Ho, 1992; Slack et al., 1992; Tam and Quinlan, 1996; Harland and Gerhart, 1997) . Cell-fate inducing signals, which are released initially from the vegetal mass of the blastula (in Xenopus) and later from the dorsal organiser (embryonic shield in zebra®sh) to induce dorso-ventral and anterior-posterior polarities in the blastula and gastrula, include members of the TGF-b, wnt and FGF superfamilies of growth factors (reviewed: Kessler and Melton, 1994; Heasman, 1997) . In contrast, little is known about the mechanisms and signals by which gastrulating cells coordinate involution and/or ingression, guide their migration as they converge to the midline, and ®nally intercalate along the dorsal axis.
Eph receptors and their ephrin ligands, along with other protein families, including netrins, semaphorins and cadherins, guide the migration of growth cones to the correct target location for synaptogenesis (for review see Kennedy and Tessier-Lavigne, 1995; Mu Èller et al., 1996; Nieto, 1996; Tessier-Lavigne and Goodman, 1996; Flanagan and Vanderhaeghen, 1998) and the targeted migration of neural crest cells in streams from the dorsal neural tube (reviewed in Robinson et al., 1997) . On the basis of sequence homology, members of the Eph subfamily of receptor tyrosine kinases (RTKs) fall into two receptor subclasses, EphA and EphB, which display af®nities for either GPI-linked (ephrin A) or transmembrane (ephrin B) ligands, respectively. The current model of Eph-ephrin signalling in growth cone path®nding involves the migration of an Ephbearing growth cone into a gradient of ephrin expression (reviewed in: Friedman and O'Leary, 1996; Pasquale, 1997; Flanagan and Vanderhaeghen, 1998) , leading to cell contact-dependent Eph receptor activation (Davis et al., 1994; Bruckner and Klein, 1998) which instructs the growth cone to change direction and avoid the ligand-rich area. Eph-ephrin interactions thus deliver a growth cone repulsion signal. For the EphA3 receptors (HEK/MEK4/CEK4) and their ephrin-A2 and A5 ligands (ELF1 and AL-1/ RAGS/zEphL4), nerve guidance functions during the development of the retinotectal projection map have been established (Cheng et al., 1995; Drescher et al., 1995; Nakamoto et al., 1996; Brennan et al., 1997; Monschau et al., 1997; Frisen et al., 1998) . In addition to the retinal axon guidance defects in the midbrain of mice lacking ephrin-A5, a significant proportion of these ephrin-de®cient mice display additional defects in dorsal midline structures, resulting in anencephaly or open crania with cleft nose and palate (Frisen et al., 1998) . This extreme phenotype suggests functions for the ephrin-A5/EphA receptor signalling system in addition to those in growth cone path®nding.
It is noteworthy that members of the Eph and ephrin families are also expressed earlier in vertebrate development, during gastrulation. EphA2 is expressed in the primitive streak of mouse embryos (Ganju et al., 1994; Ruiz et al., 1994) , and the Xenopus EphA4 homolog, pagaliaccio, is expressed during gastrulation in the involuting mesoderm (Winning and Sargent, 1994) . The Xenopus ephrin-B1 homolog is also expressed during gastrulation, and ectopic expression of this protein causes a loss of cell adhesion prior to the onset of gastrulation (Jones et al., 1998) , similar to the effect of activated pagaliaccio . In contrast, the ectopic expression of EphB2 in the ventral blastomeres of Xenopus causes dorsalisation of the embryo before the onset of gastrulation (Tanaka et al., 1998) . In zebra®sh, there are seven Eph genes, rtk1-3, rtk5, 6, 8, and zdk1 known to be expressed in a regulated manner during gastrulation (Xu et al., 1994; Taneja et al., 1996; Cooke et al., 1997) . However, sequence alignment reveals signi®cant differences to human EphA3 (A. Boyd, unpublished data) , suggesting that a zebra®sh EphA3 homologue had not yet been isolated.
The high degree of structural and functional conservation of Ephs and ephrins in vertebrate evolution has enabled the use of dominant negative mammalian EphA receptors to study the function of these proteins during zebra®sh development, and as a read-out for receptor structure-function studies (Xu et al., 1995; Xu et al., 1996; Lackmann et al., 1998) . The expression of Eph and ephrins during vertebrate gastrulation prompted us to examine potential functions of Eph-ephrin interaction in this process. We have previously established that human EphA3 interacts with a distinct hierarchy of af®nities with all ephrin-A ligands tested, whereby the highest af®nity was determined between EphA3 and ephrin-A5 (Lackmann et al., 1996; Lackmann et al., 1997) . In subsequent experiments with dominant negative human EphA3 constructs we demonstrated a role for the ephrin-binding domain of EphA receptors in embryonic axis organisation and somite formation (Lackmann et al., 1998) . The present study examines the developmental basis of this phenomenon. We demonstrate that expression of soluble forms of either human EphA3 or its high af®nity ligand ephrin-A5 in zebra®sh embryos produce indistinguishable patterns of disruption of the notochord, somites and brain. These effects are preceded by apparent cell migration defects throughout gastrulation, as indicated by perturbed ntl expression patterns around the blastula margin and during formation of the presumptive notochord. We report the identi®cation of the zebra®sh homologue of EphA3 and describe the expression pattern of the corresponding mRNA during gastrulation that is consistent with the timing and location of the dominant-negative effects. Our observations imply that EphA-ephrin-A signalling is active during involution and convergence movements and thus is required for the correct execution of gastrulation.
Results

Expression of active soluble human EphA3 and ephrin-A5 protein in the zebra®sh embryo
To evaluate the role and speci®city of Eph-ephrin interactions during early vertebrate embryogenesis we adopted a previously established dominant negative approach (Lackmann et al., 1998) . We introduced capped mRNA encoding FLAG (refers to the amino acid sequence DYKDDDDK) epitope-tagged forms of either soluble EphA3 (HEK) extracellular domain (ECD, mRNA encoding the FLAG-tagged human EphA3 ECD (sh EphA3-RNA), 10 pg per embryo) or soluble human ephrin-A5 (Lackmann et al., 1997) (mRNA encoding the soluble, FLAG-tagged form of human ephrin-A5 (sh ephrin-A5-RNA), 100 pg/embryo) into zebra®sh embryos at the 1-2 cell stage, by microinjection into the blastoderm or into the yolk cell directly under the blastoderm. Injected in this manner mRNA became widely distributed throughout the embryo (as shown by co-injection of mRNA encoding green¯uorescent protein (GFP), see Lackmann et al., 1998) and was translated into the expected proteins (Fig. 1a,b) . A marginally increased apparent molecular weight was observed for the zebra®sh-expressed sh ephrin-A5 relative to sh ephrin-A5 produced by CHO cells, suggesting increased glycosylation of the zebra®sh-produced protein (Fig. 1a) . Importantly, BIAcore analysis of zebra®sh extracts using sensorchips coated with the EphA3 ECD (for ephrin-A5 analysis) or a native conformationspeci®c anti-EphA3 MAb (for EphA3 ECD analysis) demonstrated that correctly folded and functionally-active proteins were expressed in the embryos throughout early development (Fig. 1b) . The approximate concentrations of sh EphA3 (soluble human EphA3 extracellular domain) and sh ephrin-A5 at the onset of gastrulation were 0.5 and 10 ng/ embryo respectively, rising to 3 and 25 ng/embryo respectively from 15 h post fertilisation (hpf) onwards.
2.2. Soluble human EphA3 and ephrin-A5 cause indistinguishable defects in the organisation of neurectoderm and mesoderm during early embryonic zebra®sh development Inspection of developing zebra®sh injected with 100 pg of sh EphA3 RNA revealed the presence of a distinctive syndrome of defects in approximately 50% of individuals (see also Fig. 4, below) . During gastrulation, an uneven retardation of epiboly was observed, resulting in an irregular gastrula margin relative to control embryos (data not shown). In early segmentation stages, between 11 and 15 hpf, the dorsal axis was reduced in height above the yolk surface and tailbud formation was dramatically retarded (compare Figs. 2a and 2b) . Viewed dorsally, the animals displayed a range of defects in paraxial mesoderm, including disorganisation and/or loss of somites and their boundaries, and an extension of the somitic boundary clefts into lateral regions of the embryos (compare Figs. 2d and 2e) . The notochord was often twisted (Figs. 2e and 7 below). In addition, the organisation of the anterior neurectoderm was affected, with laterally broadened and twisted mid-and hindbrain regions. Although the height of the forebrain above the yolk surface was reproducibly reduced (Fig.  2b) , the formation of the optic vesicle was not noticeably disrupted (data not shown). Exogenously expressed sh ephrin-A5 resulted in an indistinguishable phenotype in approximately 50% of zebra®sh embryos injected with 100 pg of the corresponding mRNA at all stages examined (Fig. 2c,f and see below, Fig. 4 ) consistent with a disruption of the same signalling processes inhibited by exogenous sh EphA3.
The array of differentiated embryonic structures existing by segmentation stages present a sensitive readout of the processes of gastrulation that underly their formation. Therefore, to analyse the effects of ectopic EphA3 and ephrin-A5 expression on cell fate and position in greater detail, embryos injected with a range of concentrations of sh EphA3 or sh ephrin-A5 RNA (see below, Fig. 4 ) were ®xed in early segmentation stages between 12 and 13 hpf. Whole mount in situ hybridisation was used to monitor the expression of developmentally important regulatory genes marking ventral fore-and midbrain (hlx1, Fjose et al., 1994) , midbrain-hindbrain boundary (MHB, or isthmus) (pax2.1, Krauss et al., 1991) , rhombomeres 3 and 5 of the hindbrain (krox20, Oxtoby and Jowett, 1993) , and adaxial and paraxial muscle (myoD, Weinberg et al., 1996) . The expression patterns of these genes in normal embryos at this developmental stage is illustrated in Fig. 3a,b .
In both sh EphA3 and sh ephrin-A5 RNA injected embryos there was a consistent disorganisation of the paraxial mesoderm. A highly irregular pattern in the lateral stripes of myoD expressing cells in the paraxial mesoderm con®rmed the observation in live embryos (Figs. 2e,f) that somite formation is affected. Many somites were missing or out of register across the midline (Fig. 3d,f) , whereas other myoD expressing cells were arrayed in a pattern consistent with the fusion of a somite across expected somite boundaries (Fig. 3f) . The paraxial myoD expression domains were extended more laterally from the midline (Fig. 3f) . Furthermore, the distance between myoD positive cells of the adaxial mesoderm was increased across the midline (Fig. 3d) , which was often twisted, suggesting a defect in the positioning of adaxial cells prior to somitogenesis (Weinberg et al., 1996) .
Examination of anterior neurectodermal structures of embryos injected with sh EphA3 and sh ephrin-A5 RNA revealed that the limits of groups of cells in the MHB and hindbrain expressing respectively pax2.1 and krox20, were extended laterally, often accompanied by irregular anterior and posterior boundaries (Fig. 3c,e) . Defects in the hindbrain, as revealed by krox20 expression, were always more severe than defects in the MHB; further, the rhombo- 25, 12.5, 6.25, 3 .125 ng of CHO cell-derived sh EphA3 and sh ephrin-A5 (lanes 1±4, respectively) were immunoprecipitated with anti-FLAG MAb (M2) agarose and analysed by Western blot. Zebra®sh embryos which had been injected with sh EphA3-RNA (10 pg/embryo) or sh ephrin-A5-RNA (100 pg/embryo) were lysed after 5h (lane 5) or 10 h (lanes 6,7) and analysed in parallel lanes of the gel. sh ephrin-A5 extracted from zebra®sh embryos had an increased size compared to its CHO cell-produced counterpart. (b) BIAcore analysis of lysates from sh EphA3-RNA or sh ephrin-A5-RNA-injected (100 pg/embryo) zebra®sh embryos. Samples were prepared 5, 10, 15 and 24 hpf and analysed on a sensorchip containing the conformationspeci®c anti-EphA3 MAb IIIA4 Lackmann et al., 1996) to detect the intact exogenous receptor ECD (ÐXÐ), and a sh EphA3-derivatised sensorchip to monitor functionally-intact ephrin-A5 (ÐAÐ). The responses were compared to samples of zebra®sh lysates containing known amounts of the puri®ed, CHO cell expressed proteins.
mere ®ve domain of krox20 was always more severely affected, i.e. laterally displaced than rhombomere three. Occasionally, a cluster of krox20 expressing cells was seen separated from rhombomere three or ®ve (Fig. 3c) . In contrast, a single axially located stripe of hlx1 expressing cells appeared unaffected in the sh EphA3 or sh ephrin-A5 RNA injected embryos, suggesting wildtype development of the ventral diencephalon and midbrain (Fig. 3c,e) . In these dominant negative experiments we noted a spectrum in the intensity of these defects, whereby the most severely affected embryos displayed a median gap at the midline, demarcated with krox20 and myoD expressing cells on either side (data not shown). Thus, examination of gene expression in situ in embryos injected with either sh EphA3 or sh ephrin-A5 RNA indicates defects in the organisation of mesodermal and ectodermal derivatives that suggest a disturbance of the convergence movement of cells to the dorsal midline during gastrulation. Further, using the markers available, the effects of the expression of sh EphA3 and sh ephrin-A5 on development cannot be distinguished, implying that the same developmental process(es) are disrupted in each case.
Coexpression of soluble human EphA3 and ephrin-A5 rescues defective development
We next performed experiments to address the possibility that the observed defects could be due to non-speci®c effects of the microinjections on development. Embryos were injected with mRNAs coding for proteins unrelated to Ephs or ephrins to control for disruption of development due to production of exogenous protein. Non-injected control embryos, or embryos injected with mRNA encoding GFP at a concentration of 250 pg/embryo did not display any developmental defects (Fig. 3a,b and Lackmann et al., 1998) . Embryos were also injected with mRNA encoding a FLAG epitope-tagged, soluble form of murine deleted in colon carcinoma (DCC) (Cooper et al., 1995) . The resulting protein was detected in embryo extracts at comparable levels to sh EphA3 and sh ephrin-A5 throughout development (not shown). Although expression of exogenous soluble DCC in Xenopus embryos induces a distinct axonal guidance defect (R.A. Anderson, H.M. Cooper et al., submitted) , there was no detectable disruption of adaxial and paraxial mesoderm, or mid-and hindbrain organisation in zebra®sh.
Dose-response experiments were performed to further address the possibility that the observed defects could be due to a novel, non-physiological action of EphA3 and ephrin-A5 or due to non-speci®c toxicity of the injected material. In either of these cases co-injection of sh EphA3 and sh ephrin-A5 RNA should lead to an additive increase in the number of defective embryos. A partial reduction or rescue of the defects would be expected if expression of either sh EphA3 or sh ephrin-A5 interfered speci®cally with Eph-ephrin signalling processes, as the binding of exogenous receptor and ligand would titrate the speci®c activity of both proteins. Previously we have demonstrated that the injection of increased amounts of mRNA leads to increased production of the corresponding functionally active protein (Lackmann et al., 1998) . When increasing concentrations of either sh EphA3 or sh ephrin-A5 RNA were injected into embryos, a dose-dependent increase in the number of embryos displaying the developmental syndrome described above was observed (Fig. 4) . Thus, injection of 100 pg sh ephrin-A5-RNA caused defective axis and somite organisation in approximately 50% of embryos, and injection of 10 pg sh EphA3 RNA resulted in indistinguishable defects in 35% of the treated embryos. In contrast, co-injection of sh ephrin-A5 and sh EphA3 RNA at these concentrations caused defects in only 20% of the treated embryos (Fig. 4) . Together these data demonstrate that disruption of adaxial and paraxial mesoderm and of mid-and hindbrain organisation in zebra®sh embryos injected with sh EphA3 and sh ephrin-A5 RNA is mediated by expression and speci®c activity of the corresponding proteins, and suggests that both dominant negative proteins interfere with the same endogenous Eph-ephrin mediated processes.
Soluble human EphA3 expression causes defects in the presumptive notochord during gastrulation
Our observations suggesting aberrant morphology during gastrulation, combined with the apparent defects in convergence evident by the early segmentation stage in embryos injected with sh EphA3 or sh ephrin-A5 RNA, led us to monitor cell convergence during gastrulation more closely. We used the expression of the notochord-speci®c gene ntl (Halpern et al., 1993; Schulte-Merker et al., 1994) measured by in situ hybridisation as a marker for mesodermal convergence to the midline in sh EphA3 RNA injected embryos between onset and completion of gastrulation (6±10 hpf). In untreated shield-stage (50±60% epiboly) embryos, ntl expressing cells are arranged in a uniform radial pattern, following the germ ring and marking the embryonic shield ( Fig. 5a ) (Schulte-Merker et al., 1994) . Defects in the expression pattern of the ntl expressing cells were noted in approximately 50% of sh EphA3 RNA injected embryos, ranging from a diffuse, poorly converged shield and irregular shaped blastula margin ( Fig. 5b) to lack of shield formation and scattered ntl expressing cells around the dorsal midline (Fig. 5c ). By 80±90% epiboly, ntl expressing cells of the epiblast of the non-injected embryos have converged and extended anteriorly and posteriorly along the dorsal midline Concha and Adams, 1998) to form a tight band of the presumptive notochord ( Fig. 5d ). In contrast, ntl expressing cells of injected embryos at the same developmental stage had not converged equivalently and appeared as a broadened stripe which extended over the anterior-posterior length of the dorsal midline ( Fig. 5e,f) . Furthermore, the progress of the gastrula margin at this stage and later seemed to be retarded. Experimental and control embryos derived from the same clutch were co-hybridised with pax2.1, which is expressed with increasing level in the area of the presumptive midbrain (Fig. 5g±i) , demonstrating that the illustrated embryos were analysed at equivalent stages of their development. By the end of gastrulation (95±100% epiboly) the difference between the ntl expression pattern of non-injected embryos Fig. 4 . Dose response and phenotypic rescue of sh EphA3 and sh ephrin-A5-induced developmental defects. Batches of embryos, injected with indicated amounts sh EphA3-RNA(B), sh ephrin-A5-RNA(A) or a combination of 10 pg sh EphA3-RNA and 100 pg sh ephrin-A5-RNA (g) and a constant amount of E-GFP mRNA (5 pg) were allowed to grow for 12,13 hpf before ®xation and hybridisation with pax2.1, hlx1, krox20 and myoD DIG-labelled riboprobes. Embryos were analysed under a dissecting microscope and scored for disrupted patterns of gene expression. Non-injected control embryos were scored after an identical developmental period and identical handling to the injected embryos to control for defects due to the genetic background of particular parents in our strain. None of these embryos showed any reproducible or signi®cant defects.
( Fig. 5g ; Schulte-Merker et al., 1994) and injected embryos had become less pronounced with respect to the width of the presumptive notochord (Fig. 5h,i and see below, Fig. 6a ). On the other hand, injected embryos could be distinguished by a distinctively kinked appearance of the ntl-stained notochord at this stage (Fig. 5h,i) .
In order to quantitate the effect of dominant negative hs EphA3 on the convergence of early mesodermal cells at . ntl in situ hybridisation reveals convergence defects during gastrulation in hs EphA3-expressing embryos. Batches of zebra®sh embryos were injected with 10 pg sh EphA3 mRNA and analysed at various time points during gastrulation by in situ hybridisation with a DIG-labelled riboprobes speci®c for ntl and pax2.1 (b,c,e,f,h,i). Non-injected control embryos from the same clutch were analysed in parallel (a,d,g). Embryos are oriented dorsally with anterior up, whereby examples of injected embryos with moderate (b,e,h) and severe (c,f,i) gastrulation defects are shown. (a±c) Embryos at 50±60% epiboly; ntl-staining illustrates the newly formed shield and an even path around the blastula margin in non-injected embryos (a). Closed arrows in these panels and in panels (d±f) indicate the approximate position, at which the presumptive notochord -width was determined (see (d±f) 80±90% epiboly embryos with distinct ntl staining of the presumptive notochord and of the closing yolk plug (d). Anteriorly, faint bands of pax2.1-staining are discernable. The phenotype of affected embryos ranges from a substantially widened median stripe of ntl-expressing cells and a`kinked' shape of the presumptive notochord (e) to diffuse ntl staining extending in a broad band from the yolk plug to the posterior base of pax2.1 staining (f). (g,h) Towards the end of gastrulation (95±100% epiboly) ntl staining marks the notochord as a straight line of cells from the posterior, medial tips of the pax2.1 domains (marked by arrows) to the closed yolk plug in control embryos (g), while affected embryos reveal a distinctively twisted notochord (h,i).
varying stages during gastrulation, we estimated the width across the posterior end of the presumptive notochord by counting the number of ntl-positive cells at this position in sh EphA3-RNA injected and in uninjected embryos (Fig. 6 ).
In agreement with the ®ndings illustrated above, we observed signi®cant differences by this criterion for embryos at 50±60% and 80±90% epiboly, whereas towards the end of gastrulation (95±100% epiboly) the mean notochord width was essentially the same in injected and noninjected embryos (Fig. 6a) . A more detailed analysis of the data suggests that during early and late gastrulation injected embryos can be grouped into wildtype and affected populations by the number of ntl-expressing cells across the developing notochord (Fig. 6b,c) . At 50±60% epiboly some 50% of the injected embryos displayed a wildtype distribution of 11^2 cells across the presumptive notochord, whereas the affected phenotype was characterised by a signi®cantly (Mann±Whitney U test, P , 0:01) increased width of 142 ntl-expressing cells (Fig. 6b) . Later during gastrulation (80±90% epiboly), the wildtype notochord width had decreased to 9^2 cells, while some 50% of the injected embryos display a signi®cantly (Mann±Whitney U-test, P , 0:003) increased posterior axis width of 13^2 cells (Fig. 6c) .
By early segmentation stages of development, the notochord of affected embryos injected with sh EphA3 RNA was severely deformed. In contrast to the wildtype expression of the ntl gene (Fig. 7a) , the affected phenotype of 12 hpf embryos injected with sh EphA3 RNA ranged from a distinctly twisted and shortened notochord (Fig. 7b) to structures where ntl-expressing cells formed two twisted tracks for short stretches along the anterior/posterior axis (Fig. 7c) . Parallel staining of these embryos with pax2 and krox20 probes demonstrated failure of the convergence of the presumptive mid-and hindbrain in the same embryos (Fig. 7b,c) . The appearance of ntl expression patterns during gastrulation are consistent with the twisted and broadened axial structures observed in living embryos (Fig. 2e) and inferred from the increased distance across the midline between myoD-expressing adaxial cells (Fig. 3d) . These ®ndings indicate that ectopic expression of dominant-negative EphA3 affects development from the onset of gastrulation, with defects in the convergence of cells to the midline also found in the axial mesoderm.
Expression and activity during gastrulation of zebra®sh EphA3 and ephrin-A-L1
We next assessed which EphA or ephrin-A family members are expressed during gastrulation, and hence might be subject to interference by the dominant negative hs EphA3 and ephrin-A5 constructs. Signi®cant differences in the primary protein structure of EphA3 and the known zebra®sh EphAs suggest that the zebra®sh EphA3 homologue had not been described yet. Therefore, we screened a zebra®sh library with a human EphA3 probe and isolated a cDNA clone containing partial EphA3-related DNA sequences (A. Boyd, in preparation) including the predicted C-terminal third of exon 3 (ligand binding domain), exons 4, 5 and 6 and the beginning of exon 7 (Lackmann et al., 1998) . Alignment of the corresponding amino acid sequence with homologous sequences from human (h) EphA3 and chicken (c) EphA3 (Sajjadi et al., 1991) indicated an amino acid identity of 78% (85% similarity) with human, and 77% (similarity 86%) with chicken sequences over this region. In contrast, other known zebra®sh and mammalian Eph sequences gave identity scores of less than 60%. We concluded that this clone encoded partial sequences of the zebra®sh EphA3 homologue and used the cDNA sequence to generate probes for in situ analysis of whole-mount embryos during gastrulation (Fig. 8) .
Beginning with the shield stage (6 hpf), transcripts were detectable throughout the embryo (Fig. 8a) , with marginally higher levels in the future dorsal side of the embryo (Fig.  8a,b) . Examination of later developmental stages revealed that transcripts were present in both epi-and hypoblast, although at higher levels in hypoblast (Fig. 8c,e,g ). An elevated dorsal expression in the hypoblast became more obvious at 70±90% epiboly (7±9 hpf) (Fig. 8c±f) , revealing a faint longitudinal dorsal stripe of EphA3 transcript in the region of the presumptive notochord (Fig. 8f) . At the end of gastrulation (10 hpf) the expression became most pronounced in the anterior hypoblast, including the prechordal plate (Fig. 8g) , while the fainter signal along the presumptive notochord persisted (Fig. 8g,h ). Thus the putative zebra®sh EphA3 homolog is expressed throughout gastrulation, and is a candidate for interference by the dominant negative hs EphA3 and ephrin-A5 constructs.
The homologue of human ephrin-A5, zebra®sh ephrin-A-L4, is not expressed during gastrulation (Brennan et al., 1997; C. Brennan and N. Holder, unpublished data) , however a recently characterised zebra®sh A-class ligand, ephrin-A-L1, is expressed in the gastrula margin and ventral hypoblast (Durbin et al., 1998) . Towards the end of gastrulation strong ephrin-A-L1 expression remains in a region corresponding to the presumptive tailbud, with weak expression lateral to the presumptive notochord. We initially established the ability of recombinant, CHO-cellexpressed ephrin-A-L1 protein to bind to human EphA3 by BIAcore analysis. Together with recombinant, FLAGtagged zebra®sh ephrins-A-L3 and L4, ephrin-A-L1 was expressed in CHO cells and, following puri®cation to homogeneity, passed over a sensorchip derivatized with sh EphA3 (Fig. 9) . Deconvolution of the binding reactions con®rmed the previously-described 1:1 interaction (Lackmann et al., 1997) for all analysed ligands and revealed an af®nity of ephrin-A-L4 binding to sensorchip-coupled sh EphA3 of 50 nM, which is similar to the previously reported af®nity of 12 nM of the ephrin-A5/EphA3 interaction (Table 1; Lackmann et al., 1997) . Ephrin-A-L1 and ephrin-A-L3 (zebra®sh ephrin-A2) bound to immobilised sh EphA3 with 9 and 6-fold reduced af®nities, respectively, primarily due to markedly decreased association rate constants (Table 1) .
We next assessed if zebra®sh ephrin-A-L1 would also interact with sh EphA3 in vivo, by injecting mRNA encoding sh EphA3 or soluble (s) ephrin-A-L1 proteins either separately or in combination into 1-2 cell embryos, and scoring developmental defects by in situ hybridisation analysis of myo D gene expression (Fig. 10) . Injection of mRNA encoding s ephrin-A-L1 at 60 pg/embryo resulted in 67% of the injected embryos (n 48) displaying defects reminiscent of the sh EphA3-mediated developmental defects (Fig. 10, and Durbin et al., 1998; Lackmann et al., 1998) . At this concentration of sh EphA3 RNA, 52% (n 46) of the injected embryos displayed similar defects. Co-injection of the s ephrin-A-L1 and sh EphA3 RNAs resulted in reduction of affected embryos to 34% (n 49). The rescue by s ephrin-A-L1 of the sh EphA3-induced developmental defect is thus similar to that observed with sh ephrin-A5 (compare Fig. 4 ) and indicates that s ephrin-L1 is also capable of binding to sh EphA3 in vivo. Together our experiments suggest the newly isolated zebra®sh EphA3, and ephrin-A-L1 as strong candidates for components of the endogenous Eph-ephrin signalling system that are disrupted during zebra®sh gastrulation by the expression of sh EphA3 and sh ephrin-A5.
Discussion
The fate of cells and cell layers during gastrulation has been studied in considerable detail in the zebra®sh Ho, 1992; Shih and Fraser, 1995; Woo and Fraser, 1995; Melby et al., 1996) , but little is known about the molecular mechanisms which guide the migration of these cells. We previously reported a characteristic, dosedependent syndrome, which is evident in early segmentation stage embryos and is induced by the expression of a series of truncated, soluble versions of the human EphA3 extracellular domain (Lackmann et al., 1998) . Speci®cally, truncated extracellular domains containing the ephrin-binding domain displayed biological activity, suggesting that an interaction between the EphA3 receptor and an ephrin-A ligand was responsible for the developmental defects. In this study we have extended this observation, showing that this developmental syndrome can be mimicked by the expression of the soluble human ephrin-A5. We have examined the development of these embryos in detail and present evidence that the Eph and ephrin families of cell-cell signalling proteins may have important roles in the process of gastrulation, potentially by regulating cell movements during involution and convergence.
Soluble forms of Eph and ephrins cause defects in zebra®sh development
It is well established that signalling through RTKs can be , shield stage (6 hpf): low level expression throughout the embryo, with higher levels observed in the future dorsal side (closed arrow heads). (c,d), 70% epiboly (7 hpf), expression on the dorsal half of the embryo is more pronounced and the boundary between hypoblast and epiblast becomes apparent as disconuity, whereby EphA3 expression is notably higher in the hypoblast (arrow in panels (c,e,g)). (e,f), 90% epiboly (9 hpf), showing higher expression in the future brain area as compared to the trunk (e, arrow). A faint stripe of expression extends longitudinally along the axial midline (panel f, closed arrowhead). inhibited by coexpression of kinase deleted or truncated forms of the receptor (Honegger et al., 1990; Frattali et al., 1992; Spritz et al., 1992; Reith et al., 1993; Dumont et al., 1994; Peters et al., 1994) . These ®ndings suggest that heterodimerisation between an intact endogenous receptor and an exogenous inactive counterpart will antagonise signalling in a dominant negative manner (reviewed in van der Geer and Hunter, 1994). A dominant negative approach was successful in the analysis of zebra®sh EphA4 (rtk1) function, in which the kinase-inactive form of the murine EphA4 receptor (Sek1) antagonised zebra®sh EphA4 receptor-regulated cell movements during rhombomere boundary formation (Xu et al., 1995; Xu et al., 1996) . Studies using the extracellular domain of the human EphA3 in vitro and in vivo as signalling antagonist have con®rmed the utility of the approach (Lackmann et al., 1998) .
In the case of the Eph family and their membrane-associated ephrin ligands, cell-cell contact is essential for signalling (Davis et al., 1994) , hence the soluble form of the ligand can also inhibit signalling through the receptor (Winslow et al., 1995) . In agreement with this notion, we reproduced the effect of the soluble EphA3 receptor on development (see Section 3.2) by injecting mRNA encoding sh ephrin-A5 into 1±4 cell stage zebra®sh embryos. Using BIAcore technology and western blotting, we con®rmed that both zebra®sh expressed human proteins were functionally active and abundantly expressed over the time course of our experiments (Fig. 1) . The morphology of live embryos, and the expression pattern of the hlx1, pax2.1, krox20 and myoD genes in embryos injected with sh ephrin-A5 RNA were indistinguishable from those displayed by embryos injected with sh EphA3 RNA (Figs. 2 and 3 ). This correspondence of developmental effects indicates that the same signalling process(es) were blocked by the expression of sh EphA3 and sh ephrin-A5. This conclusion is strongly supported by the ability of co-expressed receptor and ligand to correct the defects produced by either in isolation (Fig. 4) .
The high expression levels of the human proteins detected in injected embryos (Fig. 1b) , combined with the previously demonstrated speci®city of EphA class receptors for ephrin-A class ligands (Cheng and Flanagan, 1994; Brambilla et al., 1995; Lackmann et al., 1997; Monschau et al., 1997) precludes the conclusion that these effects are necessarily speci®c for the zebra®sh homologues of human EphA3 and ephrin-A5. In this regard, it is important to note that a consistent syndrome was observed for all concentrations of mRNA introduced into the embryo, though with increasing frequency and intensity at higher levels of mRNA (Fig.  4) . Additional categories of defective features would have been expected if additional low-af®nity receptor ligand interactions, for example with the Eph-ephrin B class, were successively disrupted with increasing concentration a Association and dissociation rate constants and dissociation constants were estimated for a single-site interaction model as described previously (Lackmann et al., 1997) using the BIAevaluation software, versions 2.1 and 3.0.
b The af®nity was also determined by global ®tting to a 1:1 interaction model using the BIAevaluation 3.0 software. of dominant negative protein. For example, defects involving the generation of ectopic secondary embryonic axes are seen in Xenopus embryos expressing dominant negative EphB2 or ephrin-B1 constructs (Tanaka et al., 1998) , indicating a role in dorsal speci®cation for these proteins. However, this type of defect was never observed in our studies, indicating that any potential homologous function for EphB signaling in the zebra®sh was not perturbed by a disruption of EphA3/ephrin-A5 signaling. Further, convergence defects in the zebra®sh hindbrain or paraxial mesoderm were not observed after injection of a dominant negative EphA4 construct (Xu et al., 1996; Durbin et al., 1998) . Instead, ventral diencephalon cells became incorporated into the eye ®elds, losing midline neural markers such as rtk1 and zash1 (Xu et al., 1996) . Our data showing normal expression of hlx1 in the ventral diencephalon indicates that this structure is not grossly affected by a disruption of EphA3/ephin-A5 signalling, suggesting that the defects observed here are distinct from those produced by blocking EphA4 function. From these considerations, we suggest that the early effects of ectopic expression of sh EphA3 and ephrin-A5 may be restricted to a subset of the EphA/ ephrin-A class of interactions.
Endogenous targets of disrupted EphA-ephrin-A interactions in the zebra®sh embryo
What are the endogenous targets of the exogenous sh EphA3 and ephrin-A5 proteins in the gastrula stage zebra®sh embryo? To date, eight of the 11 Eph family members described in zebra®sh, (rtk1-3, 5, 6, 8, zdk1 , and EphA3) are expressed in spatially restricted patterns at this time (Fig. 8 ) (Xu et al., 1994; Taneja et al., 1996; Cooke et al., 1997) whereas the expression of only one zebra®sh ephrin, ephrin-A-L1, has been demonstrated during gastrulation (Durbin et al., 1998) . Our data is consistent with the novel zebra®sh EphA3 being a target of the exogenous sh EphA3 and ephrin-A5 proteins. Firstly, EphA3 is expressed in a pattern that matches the site and timing of the defects, i.e. during gastrulation in the epiblast and at higher levels in the dorsal hypoblast. Secondly, as discussed in section 3.1, our disruption of Eph/ephrin signalling does not phenocopy previously described abnormalities in the early embryo caused by perturbation of (1) EphB class signalling Jones et al., 1998; Tanaka et al., 1998) or (2) other members of the EphA class (Xu et al., 1996; Durbin et al., 1998 #537) . Finally, the novel EphA3 has a higher similarity in its ligand binding domain to human EphA3 than any other known zebra®sh Eph protein, and thus would likely represent a preferential high af®nity binding partner for sh ephrin-A5. However, on the basis of their expression patterns we acknowledge the possibility of interaction with other EphA receptors, for example rtk2, 3, or 6 (Xu et al., 1994; Cooke et al., 1997) .
The zebra®sh ephrin-A5 orthologue, ephrin-A-L4 (Brennan et al., 1997) interacts with the human EphA3 receptor with an af®nity that is comparable to the interaction between the corresponding human proteins (Table 1) . However, it is clear from in situ expression studies that ephrin-A-L4 is expressed only after gastrulation (Brennan et al., 1997) , in contrast to ephrin-A-L1, which is expressed at sites and times (Durbin et al., 1998 ) that match the observed defects. Fig. 3(e,f) . myoD expressing cells do not form the parallel pattern of paraxial and adaxial mesoderm seen in non-injected embryos (arrows) and reveal areas of missing myoD expression in the somites (open arrow head) and an unevenly increased distance across the midline.
In this study we demonstrate high af®nity binding of s ephrin-A-L1 to human EphA3 in vitro. Further, the developmental defects resulting from overexpression of dominant negative s ephrin-A-L1 (Fig. 8) are indistinguishable from the sh EphA3 and sh ephrin-A5-induced defects, consistent with a functional role for EphA3/ephrin-A1 interaction in mammalian systems (Beckmann et al., 1994; Gale et al., 1996) . Importantly, coexpression of a soluble form of ephrin-A-L1 with sh EphA3 during zebra®sh gastrulation partially neutralises the effects of sh EphA3 expression, similar to the activity of sh ephrin-A5 in this context. Combined, our results strongly suggest that ephrin-A-L1 is an endogenous target for the dominant negative effects of sh EphA3 expression, and that zebra®sh EphA3 is likely to be an endogenous target for sh ephrin-A5.
The developmental syndrome associated with blocking EphA-ephrin-A interaction is consistent with a disruption of gastrulation
Extensive convergence movements during zebra®sh gastrulation bring cells from lateral positions of the epiblast and the hypoblast in the early gastrula toward the dorsal midline of the embryo Woo and Fraser, 1995; Concha and Adams, 1998) . Cells that have involuted from the epiblast at the onset of gastrulation to form the hypoblastic mesoderm (Schulte-Merker et al., 1992) are marked by the ntl gene, a zebra®sh Brachyury homologue (Schulte-Merker et al., 1994) . Our observations of perturbed gastrula morphology, combined with defects in early mesodermal ntl expression (Figs. 5±7) indicate that the antagonistic effects of sh EphA3 and sh ephrin-A5 are evident with the onset of gastrulation. As cells from lateral positions of the hypoblast converge to the dorsal margin to form the shield or dorsal organiser, an accumulation of ntl transcript is normally observed at this location. The loss of ntl expression from this marginal region in embryos with a block in EphA-ephrin-A interaction implies that involution has been locally perturbed (Fig. 5c) . Further, the increase in mediolateral width of the shield and presumptive notochord, as gauged by ntl expression, appears to indicate a signi®cant retardation of early convergence movements in embryos with disrupted EphA-ephrin-A interactions (Fig. 5b,e,f) . The notochord derives from cells within or very close to the shield region of the early gastrula (Melby et al., 1996) , and presumptive notochord cells continue to express ntl as the notochord elongates towards the animal pole by the movements of extension (Schulte-Merker et al., 1992) . Two alternative interpretations could explain why disruption of EphA-ephrin-A interactions affect convergence most markedly early in gastrulation (Figs. 5 and 6 ). Firstly, early and late phases of convergence, which differ with respect to cell movement, morphology and orientation of cell division (Concha and Adams, 1998) , may be differentially affected by a block of Eph-ephrin interactions. Alternatively, the early defects may re¯ect a delayed completion of involution and ingression at the margin rather than resulting from a perturbation of convergence. Thus the correction in notochord width seen in embryos by 10 hpf (Figs. 6a and 7b,c ) may indicate cells converging correctly, but late, at the midline.
Cells of the epiblast fated to contribute to the mid-and hindbrain also undergo extensive convergence movements during gastrulation Woo and Fraser, 1995; Concha and Adams, 1998) , whereby the more posterior cells in the neuraxis come from more lateral positions in the early gastrula, and hence have further to migrate (Woo and Fraser, 1995) . The observed lateral displacement of krox20 expressing cells of the presumptive hindbrain, and to a lesser extent, pax2.1 positive cells of the presumptive MHB, from the midline of affected embryos (Figs. 3 and 7) , suggests a correlation between the degree of disruption we observe (with rhombomere ®ve, more mediolateraly displaced than rhombomere three, and rhombomere three, more strongly displaced than the MHB), and the probable distance, the affected cells migrated during gastrulation. Notably, hlx1-expressing cells in the ventral forebrain and midbrain (Fjose et al., 1994) which are derived from a contiguous domain centered about the midline at the beginning of gastrulation (Woo and Fraser, 1995) remain relatively insulated from the effects of a blockade of EphAephrin-A interaction. Thus the correspondingly shorter convergence distance of ventral hlx1 expressing forebrain and midbrain cells over the cells of the MHB may account for the normal appearance of the hlx1 domain in embryos exhibiting MHB and hindbrain defects.
Using an early marker of muscle commitment, myoD (Weinberg et al., 1996) , we have demonstrated that a disruption of EphA/ephrin-A interaction leads to a range of defects in the organisation of cells in the paraxial mesoderm. The elongation of lateral somite boundaries away from the midline (Fig. 3f) is readily explained by a retardation of convergence, similar to that seen in the gastrulation defective mutants trilobite and knypeck ( Solnica±Krezel et al., 1995) . The localised absence of paraxial myoD expression in some embryos (Fig. 3f ) may result from a failure of ingression and involution of a particular region of the somitic anlage. Alternatively it may re¯ect a later migration defect, similar to the effect of the spadetail mutation on myoD expression, where mesoderm fated to migrate into developing trunk somites appears in the tailbud, resulting in animals with greatly enlarged tails and lacking somitic structures (Kimmel et al., 1989; Ho, 1992; Weinberg et al., 1996) . Finally, disturbance of paraxial myoD expression may result from an aberrant positioning of the paraxial mesoderm at a distance from the notochord which is outside the inductive activity of shh. Transcription of myoD throughout the paraxial mesoderm is known to be induced by Shh (Weinberg et al., 1996) and recently it has been shown, that loss of shh, as found in sonic you mutants, dramatically reduces myoD levels in adaxial cells and more lateral somitic mesoderm (Schauerte et al., 1998) .
The fusion of somite boundaries and loss of register between boundaries across the midline that we observed in some of the injected embryos (Fig. 3d,f) is reminiscent of treatments and mutations that affect the anterior-posterior segmentation process of the paraxial mesoderm (van Eeden et al., 1996; for review, see: McGrew and Pourquie, 1998) , raising the possibility that the disruption of EphA-ephrin-A signalling may perturb segmentation or somitogenesis directly. The expression patterns in mice and rats would support the possibility of Eph-ephrin interactions during somitogenesis (Cheng and Flanagan, 1994; Donoghue et al., 1996; Gale et al., 1996; Kilpatrick et al., 1996; Flenniken et al., 1997) . Indeed, we have demonstrated recently, that expression of dominant negative EphB2, EphA4 or ephrin-A-L1 affects somite boundary formation (Durbin et al., 1998) . Thus a contribution of EphA4 or ephrin-A-L1 to some of the observed defects in somite organisation seems likely. Importantly, although the segmental expression of myoD in the paraxial mesoderm was lost in the most severe dominant negative EphA4 phenotypes (Durbin et al., 1998) , in no instance was an effect on the adaxial cells observed. By contrast, the twisted appearance of the notochord and adaxial cells of early segmentation stage embryos with disrupted EphA/ephrin-A interactions in the present study suggests dramatically disturbed convergence movements in the trunk of these animals which would result in a perturbation of paraxial mesoderm prior to the localised somite boundary formation of segmentation.
Potential mechanisms of EphA-ephrin-A activity during gastrulation
As described above, interference in Eph-ephrin signalling appears to perturb multiple processes during gastrulation. The evidence is consistent with a disruption of involution and/or ingression, as well as the later convergence of both epi-and hypoblast. The current view of the role of EphA/ ephrin-A interactions during growth cone and neural crest cell migration is the delivery of a repulsive signal that causes the moving cell to select a path that avoids high concentrations of ligand (for review : Flanagan and Vanderhaeghen, 1998) . It is not clear how the endogenous EphA3 and ephrin-A-L1 proteins, likely to be disrupted by our treatment, would be mediating this type of behaviour during early gastrulation, but it is intriguing that the two genes appear in complementary expression gradients in the late gastrula (70% epiboly). This does not preclude the involvement of other, as yet unknown, EphA or ephrin-A family members with appropriate expression patterns in speci®c contact repulsion based guidance tasks during gastrulation.
Importantly, depending on the Eph-ephrin interaction and the cell type involved, biological responses other than repulsion have been noted for Eph receptors. For example, ephrin-A1 is competent to cause endothelial cell chemotaxis and capillary assembly ( Pandey et al., 1995; Daniel et al., 1996) , and mice lacking ephrin-B2 do not remodel vascular plexi into properly branched vessels . Stein et al. (1998) Multiple cell adhesion molecules such as ®bronectin and members of the cadherin and integrin families are expressed, and regulate, cell migration and intercalation during vertebrate gastrulation (reviewed by Winklbauer et al., 1996) . The ability of activated EphA4 and overexpressed ephrin-B1 to cause a loss of cell adhesion in the Xenopus blastula Jones et al., 1998) indicates that perturbation of Eph/ephrin signaling can lead to defective adhesion in the embryo, albeit at developmental times earlier than the defects observed here. In contrast, loss of the function of the cell adhesion molecule paraxial protocadherin (papc) in both zebra®sh and Xenopus leads to defects in convergence of the trunk mesoderm highly reminiscent of those observed in this study Yamamoto et al., 1998) . Further, expression of papc drives the elongation of sensitised animal cap explants by causing the cells to intercalate in the same way as seen during convergent extension . Together these ®ndings would support an alternative mechanism of EphA/ephrin-A activity, whereby the gastrulation defects observed after disruption of EphA/ephrin-A interactions may be due to a change in cell-cell adhesion, preventing correct migratory and perhaps intercalation behaviour. For example, both EphA3 and ephrin-A-L1 are radially expressed in the hypoblast of the early gastrula, and EphA3 is found in addition in the overlying epiblast. Loss of EphA3/ephrin-A-L1 interaction between these cell layers may result in an inability of cells at the margin to de-and readhere during involution and ingression, producing the aberrant epibolic margin and ntl expression patterns we observed. We must offer the caveat that our analysis is based on the movements of cells as large groups in the embryo, and that we cannot comment on the migratory behaviour of single cells under the effect of disrupted EphA-ephrin-A interactions during gastrulation. We are currently testing these ideas to determine the mechanisms of perturbation in detail.
Finally, we note that a loss-of-function-mutation in the C. elegans Eph homologue, vab-1, results in a failure in the movements of neuronal cells in gastrulation cleft closure, and in the migration of epidermal cells to complete ventral enclosure of the epidermis immediately thereafter (George et al., 1998) . The similarity of these defects and those evident in vertebrate embryos with disrupted EphA-ephrinA interaction shown here implies an ancient evolutionary usage of Eph receptors in the execution of the complex morphogenetic movements of gastrulation, and suggests that Eph-ephrin interaction may be a general mechanism for regulation of cell movement.
Experimental procedures
Fish care and embryo collection
Wildtype zebra®sh were obtained from St. Kilda Aquarium (Melbourne) and kept essentially as described (Wester®eld, 1995) . Embryos were obtained by natural spawning between a small number (4±10) of male and female ®sh. Embryos were removed from the spawning tanks within 20 min of fertilisation, cleaned in system water, and transferred to the injection apparatus.
Screening of a zebra®sh cDNA library
A 28 h zebra®sh embryo cDNA library cloned into the ZAP vector was screened using a 660 bp human EphA3 probe generated by PCR from primers at either end of the third exon encoding the ligand binding domain (Lackmann et al., 1998) . The probe was 32 P labelled using a Megaprime labelling kit (Amersham). A total of 2 £ 10 6 plaques were transferred onto duplicate ®lters which were then pre-hybridized (5 £ Denhardts solution, 5 £ SSPE, 0.1 mg/ml salmon sperm DNA, 0.5% SDS) for 4 h and hybridized with 32 P labelled probe over-night. The ®lters were washed in SSPE/ 0.1% SDS, twice at room temperature and twice at 608C. Duplicate positives plaques were identi®ed by autoradiography and isolated for puri®cation of postive clones. Best®t analysis of the amino acid sequence encoded by the clone identi®ed amino acids 214±477 of the published hEphA3 sequence . This includes the C terminal third of exon 3, exons 4, 5 and 6 and the beginning of exon 7 (Lackmann et al., 1998) . Best®t analysis was performed against homologous sequences from human (hEphA3) and chicken (c EphA3) (Sajjadi et al., 1991) .
RNA synthesis and microinjection
Constructs equivalent to FLAG-tagged, soluble human EphA3 extracellular domain (sh EphA3) and soluble ephrin-A5 (sh ephrin-A5) were generated by PCR from cDNA constructs encoding the FLAG-tagged soluble human proteins (Lackmann et al., 1997) . In each case the 5 H oligonucleotide was based on the IL-3 signal sequence and the 3 H oligos were as above, except that BglII sites were used to clone the PCR products into the pSP64TK vector. The cDNA encoding truncated, soluble ephrin-A-L1 was prepared as described (Durbin et al., 1998) . mRNA from the EphA3, ephrin-A5 and ephrin-A-L1 constructs and control GFP and mDCC cDNA constructs were transcribed in vitro (message maker kit, Ambion, Texas) and resuspended in water at 0.1 mg/ml. Integrity of the mRNA was checked by denaturing gel electrophoresis. Immediately prior to injection, aliquots of sh EphA3-RNA or sh ephrin-A5-RNA were thawed and adjusted with water and GFP mRNA to deliver either 10 pg, 1 pg, or 0.1 pg of the sh EphA3-RNA, 10 pg or 100 pg of the sh ephrin-A5-RNA and 5 pg of the GFP mRNA or 10 pg of the sh EphA3-RNA and 100 pg of the sh ephrin-A5-RNA to each embryo. Approximately 600 pl of RNA solution was injected into the blastoderm or yolk of one, two or four cell embryos under a Wild stereo microscope using Leitz micromanipulators (Leitz, Wetzlar, Germany) and compressed nitrogen. Uptake and translation of mRNA by the embryo was measured by including 5 pg mRNA encoding EGFP as a marker in each injection.
4.4. Analysis of sh EphA3 and sh ephrin-A5 production in zebra®sh embryos by Western blot and BIAcore analysis Translation of EphA3, ephrin-A5 and DCC mRNA was measured at intervals during embryogenesis by Western blotting and the abundance of functionally-active proteins by BIAcore analysis of whole embryo lysates. Ten embryos per 0.1 ml sample were lysed in buffer (25 mM Tris±HCl, pH 7.4, 0.5 M NaCl, 1% Triton X-100) containing protease inhibitors (1 mM PMSF/1 mM EDTA/5 mM E64 (transepoxysuccinyl-L-3-methyl-butane, Boehringer Mannheim) /10 mM leupeptin, 10 mM pepstatin/1 mM 1,10-Phenanthroline), the lysate cleared by centrifugation (60 min, 1 £ 10 5 £ g) and stored at 2 808C until use. For comparison, CHO cell-derived sh EphA3 and sh ephrin-A5 (as indicated) were added to lysates of non-injected embryos. Samples were extracted individually using 7.5 ml of packed anti-FLAG MAb (M2) agarose (IBI, Kodak), washed (0.5 ml each) with lysis buffer and Tris-buffered saline (TBS) and eluted with 2 £ 15 ml of 0.15 mg/ml FLAG peptide in TBS. Parallel samples were analysed either by SDS-PAGE and Western blot using biotinylated anti-FLAG M2 MAb (IBI, Kodak) and HRP/streptavidin (Boehringer, Mannheim) for enhanced chemiluminescence detection (ECL, Pierce) or analysed on the BIAcore. BIAcore sensor chips were derivatised with anti-EphA3 MAb IIIA4 or sh EphA3 as described (Lackmann et al., 1996; Lackmann et al., 1997) . Lysates of zebra®sh embryos which had been injected with sh EphA3-RNA or sh ephrin-A5-RNA were analysed in parallel with samples of zebra®sh lysates containing known concentrations of the CHO cell-derived proteins. A linear correlation (r 0:998) between increasing concentration of added protein and BIAcore response was obtained routinely.
4.5. Kinetic BIAcore analysis of the interaction between ephrin-A-L1, ephrin-A-L3, ephrin-A-L4 or sh ephrin-A5 and sh EphA3
The methodology for the expression, puri®cation and kinetic analysis of FLAG-tagged ephrins has been described previously in detail (Lackmann et al., 1997) . Brie¯y, recombinant, soluble FLAG-tagged forms of ephrin-A-L1, ephrin-A-L3, ephrin-A-L4 or ephrin-A5 were obtained from culture supernatants of CHO cells which had been stably transfected with the pEFBOS vector containing the relevant cDNA; homogenous preparations of these proteins were obtained by af®nity and size-exclusion chromatography and the protein concentration determined as described previously (Lackmann et al., 1997) . The binding of the various ephrins to the sh EphA3-coated BIAcore sensor chip surface (Lackmann et al., 1997) was performed at 25 ml/min to avoid ambiguities due to mass-transport problems as instructed by the manufacturer (BIAcore AB, Sweden).
The interaction kinetics were derived from the BIAcore raw data essentially as described (Lackmann et al., 1997) and by global ®tting analysis using the BIA evaluation software (version 2.1 and version 3.0).
Whole mount RNA in situ hybridisation
The effects of each of the injected mRNAs on embryonic development was measured at 6±15 hpf, i.e. from the shield stage to ®ve to eight somite stage (Kimmel et al., 1995) by light microscopy and in situ hybridisation with probes to hlx1 (Fjose et al., 1994) , pax2.1 (Krauss et al., 1991) , krox20 (Oxtoby and Jowett, 1993) , myoD (Weinberg et al., 1996) and ntl (Schulte-Merker et al., 1994) . Embryos were scored as defective if the wildtype pattern of gene expression was disrupted. Riboprobe synthesis and in situ hybridization were carried out essentially as described (Schulte-Merker et al., 1992) with the following modi®ca-tions: riboprobes were puri®ed before use over RNA sephadex G-50 columns (Boehringer, Mannheim). Using estimates of RNA synthesis based on 32 P-CTP incorporation, probes were resuspended in HYB 1 at a concentration of 1 ng/ml for use. Embryos were not proteinase K digested. Hybridization and washing was carried out at temperatures of 65±708C. Non-speci®c binding of anti-digoxygenin Fab-AP (Boehringer Mannheim), used at a dilution of 1/5000, was blocked with 10% w/v Blocking Reagent (Boehringer Mannheim)/25 heat-inactivated sheep serum/MABT (100 mM Maelic acid, 150 mM NaCl, 0.1% Tween-20, pH 7.5) for 1 h at room temperature. Color detection reactions utilized BM purple substrate (Boehringer Mannheim), and were developed for up to 2 days before ®xing in 4% paraformaldehyde/PBT. Embryos were either cleared in glycerol or benzyl benzoate: benzyl alcohol (2:1) and photographed using a Leitz Wild T stereo dissection microscope or a Nikon Microphot AX compound microscope.
